Biblio

Author Title [ Type(Asc)] Year
Filters: Author is Yang, Yong-Guang  [Clear All Filters]
Journal Article
Tena AA, Sachs DH, Mallard C, Yang Y-G, Tasaki M, Farkash E, Rosales IA, Colvin RB, Leonard DA, Hawley RJ. Prolonged Survival of Pig Skin on Baboons After Administration of Pig Cells Expressing Human CD47. Transplantation. 2016.
Wang J, Mao K, Cong X, Tan H, Wu C, Hu Z, Yang Y-G, Sun T. Nanoparticle delivery of siRNA suppresses alloimmune responses by inhibiting activation and differentiation of DCs and macrophages. Sci Adv. 2022;8(51):eabq3699.
Xia J, Hu Z, Yoshihara S, Li Y, Jin C-H, Tan S, Li W, Chen Q, Sykes M, Yang Y-G. Modeling Human Leukemia Immunotherapy in Humanized Mice. EBioMedicine. 2016.
Fang M, Zou J, Xu F, Wang X, Hua S, Zhou Q, Yang Y-G, Hu Z. Modeling human anti-pig xenoimmune responses in a pig artery tissue grafted humanized mouse model. Xenotransplantation. 2023:e12824.
Cong X, Tan H, Lv Y, Mao K, Xin Y, Wang J, Meng X, Guan M, Wang H, Yang Y-G, et al. Impacts of cationic lipid-DNA complexes on immune cells and hematopoietic cells . Biomater Sci. 2024.
Ren J, Yu D, Fu R, An P, Sun R, Wang Z, Guo R, Li H, Zhang Y, Li Z, et al. IL2RG-deficient minipigs generated via CRISPR/Cas9 technology support the growth of human melanoma-derived tumours. Cell Prolif. 2020:e12863.
Ji T-T, Niu S-S, Fang M-H, Xu L-X, Wang X, Zou J, Xu F, Zhang M, Niu R, Wu J, et al. Genome editing HLA alleles for a pilot immunocompatible hESC line in a Chinese hESC bank for cell therapies. Cell Prolif. 2023:e13471.
Xu L, Wang X, Zhang T, Meng X, Zhao W, Pi C, Yang Y-G. Expression of a mutant CD47 protects against phagocytosis without inducing cell death or inhibiting angiogenesis. Cell Rep Med. 2024;5(3):101450.